文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

新冠疫情期间非洲常规儿童免疫的效益-风险分析

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
PubMed 文献 · Lancet Glob Health · 2020-07-17

该分析比较了非洲维持常规儿童免疫的健康收益与因前往接种点而感染SARS-CoV-2并致死的超额风险。高影响情景下,每1例接种门诊相关超额新冠死亡对应可预防84例(95%UI 14-267)儿童死亡;低影响情景仅计麻疹 outbreak 避免死亡时,对接种儿童家庭的效益-风险比为3(0-10)。作者认为维持常规儿童免疫的收益大于风险。

要点

  • 高影响情景下每1例接种门诊相关超额新冠死亡对应预防84例儿童死亡(95%UI 14-267)。
  • 对接种儿童自身的效益-风险比为85 000(4900-546 000)。
  • 低影响情景仅计麻疹时对接种儿童家庭效益-风险比为3(0-10)。

核心结论

  • 在非洲维持常规儿童免疫所避免的死亡超过接种门诊就诊相关的超额COVID-19死亡风险,尤其是对接种儿童本身。

研究设计与样本

  • 采用高影响情景与低影响情景两种假设,估算COVID-19疫情期间免疫覆盖率下降可能导致的儿童死亡。
  • 高影响情景利用既往报告的国别儿童死亡率影响估计,涵盖白喉、破伤风、百日咳、乙肝、b型流感嗜血杆菌、肺炎链球菌、轮状病毒、麻疹、A群脑膜炎、风疹和黄热病疫苗。
  • 低影响情景仅估算COVID-19风险期内麻疹暴发所避免的儿童死亡。
  • 假设接触减少措施压平流行曲线、风险期结束时60%人口已感染、儿童可由接种员或运输途中感染、儿童感染后全家感染。
  • 应用国别家庭年龄结构与年龄别感染病死率计算接种门诊就诊归因死亡数,并给出效益-风险比及95%不确定性区间(UI)。

主要发现

  • 高影响情景下,每1例因常规接种门诊就诊感染SARS-CoV-2导致的超额COVID-19死亡,可预防84例(95%UI 14-267)儿童死亡。
  • 对接种儿童的效益-风险比为85 000(4900-546 000),对其兄弟姐妹(<20岁)为75 000(4400-483 000)。
  • 对父母或成年照护者(20-60岁)的效益-风险比为769(148-2700),对老年人(>60岁)为96(14-307)。
  • 低影响情景下,仅计麻疹暴发避免的儿童死亡时,对接种儿童家庭的效益-风险比为3(0-10)。
  • 低影响情景下若仅考虑接种儿童自身风险,效益-风险比为3000(182-21 000)。

关键数值与推荐

  • 高影响情景效益-风险比:每1例超额COVID-19死亡对应84例(95%UI 14-267)儿童死亡被预防。
  • 接种儿童效益-风险比85 000(4900-546 000);兄弟姐妹75 000(4400-483 000);父母或成年照护者769(148-2700);老年人96(14-307)。
  • 低影响情景对接种儿童家庭效益-风险比3(0-10);仅计接种儿童自身为3000(182-21 000)。
  • 情景假设:风险期结束时60%人口已感染,儿童感染后全家感染。

临床怎么用

  • 在非洲COVID-19疫情期间应尽可能维持常规儿童免疫,同时考虑物流限制、人员短缺和资源重新分配等因素。

局限性

  • 原文摘要未明确列出局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National immunisation programmes globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits of sustaining routine childhood immunisation in Africa with the risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection through visiting routine vaccination service delivery points. METHODS: We considered a high-impact scenario and a low-impact scenario to approximate the child deaths that could be caused by immunisation coverage reductions during COVID-19 outbreaks. In the high-impact scenario, we used previously reported country-specific child mortality impact estimates of childhood immunisation for diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae, rotavirus, measles, meningitis A, rubella, and yellow fever to approximate the future deaths averted before 5 years of age by routine childhood vaccination during a 6-month COVID-19 risk period without catch-up campaigns. In the low-impact scenario, we approximated the health benefits of sustaining routine childhood immunisation on only the child deaths averted from measles outbreaks during the COVID-19 risk period. We assumed that contact-reducing interventions flattened the outbreak curve during the COVID-19 risk period, that 60% of the population will have been infected by the end of that period, that children can be infected by either vaccinators or during transport, and that upon child infection the whole household will be infected. Country-specific household age structure estimates and age-dependent infection-fatality rates were applied to calculate the number of deaths attributable to the vaccination clinic visits. We present benefit-risk ratios for routine childhood immunisation, with 95% uncertainty intervals (UIs) from a probabilistic sensitivity analysis. FINDINGS: In the high-impact scenario, for every one excess COVID-19 death attributable to SARS-CoV-2 infections acquired during routine vaccination clinic visits, 84 (95% UI 14-267) deaths in children could be prevented by sustaining routine childhood immunisation in Africa. The benefit-risk ratio for the vaccinated children is 85 000 (4900-546 000), for their siblings (<20 years) is 75 000 (4400-483 000), for their parents or adult carers (aged 20-60 years) is 769 (148-2700), and for older adults (>60 years) is 96 (14-307). In the low-impact scenario that approximates the health benefits to only the child deaths averted from measles outbreaks, the benefit-risk ratio to the households of vaccinated children is 3 (0-10); if the risk to only the vaccinated children is considered, the benefit-risk ratio is 3000 (182-21 000). INTERPRETATION: The deaths prevented by sustaining routine childhood immunisation in Africa outweigh the excess risk of COVID-19 deaths associated with vaccination clinic visits, especially for the vaccinated children. Routine childhood immunisation should be sustained in Africa as much as possible, while considering other factors such as logistical constraints, staff shortages, and reallocation of resources during the COVID-19 pandemic. FUNDING: Gavi, the Vaccine Alliance; Bill & Melinda Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Abbas K, Procter SR, van Zandvoort K, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020. PMID: 32687792. doi:10.1016/S2214-109X(20)30308-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。